Electromed Inc. (NYSEAMERICAN:ELMD) is one of the most promising micro-cap stocks according to analysts. On February 10, Electromed achieved its 13th consecutive quarter of year-over-year revenue and profit growth, reporting record net revenues of $18.9 million for FQ2 2026. This 16.3% increase was primarily driven by the company’s core home care business, which grew 18.4% to $17.3 million. This surge was supported by a highly productive sales force that averaged $1.2 million in annualized revenue per representative, exceeding the company’s target range.
Additionally, the launch of Brensupri, the first FDA-approved drug for bronchiectasis, has heightened market awareness, complementing the use of Electromed’s SmartVest system. The company’s focus on operational execution led to a record operating income of $3.6 million, a 42.4% increase over the previous year. Net income also hit a record $2.8 million, resulting in earnings per share of $0.32.
Photographee.eu/Shutterstock.com
Management at Electromed Inc. (NYSEAMERICAN:ELMD) remains focused on closing the treatment gap for the 58% of qualifying patients who do not yet receive HFCWO therapy, supported by the execution of 25 new payer contracts that added 2.9 million covered lives to their potential patient base.
Electromed Inc. (NYSEAMERICAN:ELMD) develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation/HFCWO therapy in pulmonary care for patients in the US and internationally.
While we acknowledge the potential of ELMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 11 Best Small Cap Tech Stocks With High Upside Potential.
Disclosure: None. Follow Insider Monkey on Google News.
